Developer docs
API playgroundTry for free, no card

Search company profiles

Ingenes

Full company profile

uuid000j1k5

Namestring
Ingenes
Legal namestring
Instituto de Infertilidad y Genética México, S.C.
Websiteurl
ingenes.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Ingenes (legal name Instituto de Infertilidad y Genética México, S.C.) is a Mexico City-headquartered fertility institute founded in 2005 by Dr. Felipe Camargo, operating 20+ owned clinics across Mexico (Mexico City, Monterrey, Guadalajara, Querétaro, Mérida, Tijuana, Puebla) and the United States (San Diego, McAllen/Edinburg, Houston, Orange County) with 501–1,000 employees. The company provides assisted reproduction services — IVF, ICSI, PICSI, artificial insemination, egg/sperm donation and preservation, surrogacy, and maternal-fetal care — to heterosexual couples, LGBTQ+ couples, single individuals and international medical tourists from 40+ countries, reporting 75,000+ babies born cumulatively. Its differentiator is the proprietary TripleMed® platform, which integrates reproductive medicine with regenerative/genetic medicine (Ovagen® ovarian regeneration, Endogen® endometrial restoration, IVF MORE® mitochondrial restoration, Procelk® exosome therapy, PGT-A/PGT-M genetic testing, Eligender® sex selection, Clarix® NIPT) and metabolic medicine (Longevity Test, personalized ketogenic nutrition) under a single clinical roof. The business model combines fee-for-service treatment packages — closed-price multi-cycle programs with a partial money-back guarantee — with a B2B corporate wellness channel covering 500+ multinational employers and a 1,000+ referring-physician network. International patient services are coordinated through virtual consultations, travel logistics and multilingual follow-up. Ingenes is privately held with no disclosed external funding; Cofepris license, REDLARA Gold lab certification, ASRM and ESHRE affiliations provide regulatory anchoring, and US operations operate under HIPAA as a unified business unit.

Short descriptiontext

Ingenes is a Mexico-headquartered fertility institute operating 20+ clinics across Mexico and the United States, delivering IVF, regenerative and genetic reproductive medicine, and surrogacy programs to individuals, couples and medical tourists from 40+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersMexico City, Mexico
HQ citystring
Mexico City
HQ countrystring
Mexico
HQ regionstring
Latin America
Markets served

Serves global market

Offices11 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fertility treatments, assisted reproduction, in vitro fertilization, reproductive medicine, surrogacy services
Industry3 codes
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAC
Reproductive Endocrinology & Infertility (IVF/Fertility)
SECONDARYHLALAHAA
Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
NAICS code1 code
  • Family Planning Centers621410
SIC code3 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Fertility and Reproductive Medicine Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Treatment Services
TypeTransaction Fee
Description

Ingenes generates revenue primarily through fee-for-service medical treatments including IVF, ICSI, insemination, surrogacy programs, egg/sperm preservation, donation programs, and maternal-fetal care. Treatments are sold as multi-cycle program packages with closed pricing (multiple cycles included in one price), with medication, studies, and procedures bundled.

ingenes.com
2Multi-Cycle Programs with Money-Back Guarantee
TypeUsage Based
Description

Multi-cycle program bundles with partial refund if pregnancy is not achieved after contracted cycles. This de-risks the patient purchase decision and drives conversion for high-complexity treatments.

ingenes.com
3Corporate Wellness Agreements
TypeSubscription Recurring
Description

Over 500 multinational corporations purchase preferential access to Ingenes fertility benefits for their employees under corporate agreements, providing a B2B revenue stream.

ingenes.com
4International / Medical Tourism
TypeTransaction Fee
Description

Patients from more than 40 countries travel to Ingenes locations in Mexico and the US, generating international patient revenue with coordinated travel, treatment, and follow-up services.

ingenes.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Pricing details1 tier
1Multi-Cycle Programs with Guarantee
ModelOutcome Based/ PerformanceBilling cadenceMulti-year contract
Notes

Closed-price multi-cycle packages covering multiple IVF attempts, with medications, studies, and procedures included. If pregnancy is not achieved after contracted cycles, a partial refund is provided.

ingenes.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 7 records shown
1TripleMed®
Description

Proprietary integrated medicine approach combining reproductive medicine, regenerative and genetic medicine, and metabolic medicine under one roof.

ingenes.com
+6 more records
Core offering1 text field

Ingenes operates a network of fertility clinics providing assisted reproduction treatments (IVF, ICSI, PICSI, artificial insemination), egg and sperm donation and preservation, surrogacy programs, and proprietary regenerative therapies (Ovagen®, Endogen®, IVF MORE®, Procelk®) under its integrated TripleMed® platform combining reproductive, regenerative/genetic, and metabolic medicine. It serves individual patients and couples (heterosexual, LGBTQ+, single) via 20+ branches in Mexico and the US, with closed-price multi-cycle packages and corporate wellness agreements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 75,000+ babies born over 20 years of operation
+3 more records
Product overview1 text field

Ingenes is a reproductive health institute offering a comprehensive portfolio of assisted reproduction and fertility treatments, organized around its proprietary TripleMed® approach that integrates reproductive medicine, regenerative and genetic medicine, and metabolic medicine. The core offerings include FIV/ICSI/PICSI treatments, artificial insemination, egg and sperm donation services, fertility preservation, and the IVF MORE® mitochondrial restoration technique. Specialized services encompass genetic testing (PGT-A, PGT-M), sex selection (Eligender®), stem cell therapies (Ovagen®, Endogen®, Procelk®), and surrogacy programs. The institute operates 20+ branches across Mexico and the United States, serving patients from over 40 countries.

Product and service17 records
1TripleMed® Integrated Fertility Program
CategoryFertility Treatment Program
Description

Comprehensive fertility treatment program integrating reproductive medicine (IVF, ICSI, insemination, surrogacy), regenerative and genetic medicine (stem cells, PGT-A/PGT-M, sex selection), and metabolic medicine (longevity testing, personalized nutritional intervention) for individuals and couples facing complex infertility.

2In Vitro Fertilization (FIV)
CategoryReproductive Treatment
Description

High-complexity assisted reproduction procedure for couples facing infertility challenges, including gamete retrieval, fertilization in laboratory, and embryo transfer.

3FIV with ICSI
CategoryReproductive Treatment
Description

IVF with intracytoplasmic sperm injection (ICSI), where a single sperm is directly injected into an egg for severe male factor infertility cases.

4FIV with PICSI
CategoryReproductive Treatment
Description

IVF with physiological ICSI (PICSI), selecting mature sperm based on hyaluronic acid binding to improve fertilization outcomes.

5Artificial Insemination
CategoryReproductive Treatment
Description

Low-complexity assisted reproduction treatment involving timed intrauterine insemination for patients with compatible infertility profiles.

6Egg Donation (Ovodonación)
CategoryDonor Gamete Service
Description

Egg donation service using donor eggs for patients who cannot use their own eggs, accessed through the Mexican egg bank.

7Sperm Donation
CategoryDonor Gamete Service
Description

Sperm donation service for patients requiring donor sperm, sourced from the Mexican and international sperm banks.

8Egg Preservation
CategoryFertility Preservation
Description

Egg preservation (egg freezing) service for women delaying childbearing for social, oncological, or gender-transition-related reasons.

9Sperm Preservation
CategoryFertility Preservation
Description

Sperm cryopreservation service for men, including those facing medical treatments affecting fertility.

10Ovagen® Ovarian Regeneration
CategoryRegenerative Treatment
Description

Proprietary ovarian tissue regeneration therapy using stem cells, targeting women with low ovarian reserve including those aged 38–45 told their eggs are no longer viable.

11Endogen® Endometrial Regeneration
CategoryRegenerative Treatment
Description

Proprietary endometrial regeneration therapy using stem cells to restore a damaged endometrium to receptivity for implantation in patients with failed IVF cycles.

12IVF MORE® Egg Mitochondrial Restoration
CategoryRegenerative Treatment
Description

Proprietary mitochondrial restoration therapy that rejuvenates eggs at the mitochondrial level, offered to patients with multiple failed IVF attempts and no clear answers.

13Procelk® Exosome-Based Stem Cell Therapy
CategoryRegenerative Treatment
Description

Proprietary exosome-based therapy applied to enhance gamete and embryo quality, used as part of the regenerative medicine branch within TripleMed.

14PGT-A Preimplantation Genetic Testing
CategoryGenetic Diagnostic Test
Description

Preimplantation genetic testing for aneuploidy (PGT-A) to screen embryos for chromosomal abnormalities before transfer.

15PGT-M Preimplantation Genetic Testing
CategoryGenetic Diagnostic Test
Description

Preimplantation genetic testing for monogenic disorders (PGT-M) to screen embryos for specific inherited genetic conditions before transfer.

16Eligender® Sex Selection
CategoryGenetic Selection Service
Description

Sex selection service using genetic testing to choose the sex of the embryo for family balancing, offered as an additional service within the TripleMed framework.

17Clarix® Non-Invasive Prenatal Test
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Over 500 multinational corporations have corporate agreements with Ingenes that include fertility medicine benefits for their teams. These agreements provide employees with preferential access, special conditions, and integral support for treatments including IVF, preservation, donation, and surrogacy.

21,000+ Referring Physicians (gynecologists, endocrinologists, specialists)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

More than 1,000 gynecologists, endocrinologists, and specialists refer patients to Ingenes from multiple countries. Ingenes works as a team with the treating physician, coordinates treatment, and returns the patient with complete follow-up to the referring doctor.

ingenes.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

US-based fertility clinic network offering IVF, ICSI, PGT, and preservation across multiple sites. Comparable as a multi-clinic fertility operator with outcomes reporting, though more concentrated in the US than Ingenes' Mexico/US model.

2Instituto Valenciano de Infertilidad (IVI)
TypeDirect peer
Description

Pioneering Spanish fertility institute that pioneered many techniques now standard across the industry; comparable to Ingenes on research-driven positioning, multi-country footprint, and international patient focus.

TypeDirect peer
Description

US fertility clinic known for mild/mini-IVF protocols and high-volume international patient flow. Comparable to Ingenes on medical tourism orientation and on serving complex or repeat-failure patient cases.

TypeRegional player
Description

Australian fertility clinic and technology provider operating a multi-site network across Australia and selected international markets. Comparable on clinic-network scale and proprietary lab/embryology investments, though regional.

TypeDirect peer
Description

World's largest fertility clinic network (now under KKR ownership) offering IVF, ICSI, PGT, egg donation, and preservation across Europe, Latin America, and beyond. Most directly comparable to Ingenes as a multi-country fertility chain with strong medical tourism and B2B employer channels.

TypeBroad incumbent
Description

Major US fertility chain (part of Unified Women's Healthcare) with shared-risk and multi-cycle refund programs that closely mirror Ingenes' Programas Multiciclo structure, making it a direct comparator on outcomes-based pricing and employer benefit partnerships.

7Reproductive Medicine Associates of New Jersey (RMANJ)
TypeBroad incumbent
Description

Large US fertility practice group with high-volume outcomes reporting and PGT-focused programs. Comparable on outcome transparency, multi-clinic fertility operations, and integration of advanced genetic testing into the standard IVF pathway.

TypeRegional player
Description

Madrid-based fertility clinic catering significantly to international patients, particularly from Latin America and the Middle East. Comparable to Ingenes on cross-border medical tourism and premium positioning, though serving European rather than Mexican capacity.

TypeDirect peer
Description

European fertility chain (formerly part of the NMC group) with cross-border patient flow from Latin America, including egg donation programs and multi-cycle packages. Comparable to Ingenes as a cross-border fertility operator with strong Latin American demand.

TypeBroad incumbent
Description

Large US fertility clinic network with proprietary lab protocols and aggressive expansion. Comparable on integrated reproductive + genetic medicine positioning and on multi-site specialty fertility model, though without Ingenes' regenerative medicine and medical tourism angles.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ingenes

Fertility and Reproductive Medicine Servicesingenes.com

Ingenes is a Mexico-headquartered fertility institute operating 20+ clinics across Mexico and the United States, delivering IVF, regenerative and genetic reproductive medicine, and surrogacy programs to individuals, couples and medical tourists from 40+ countries.

What Ingenes does

Ingenes (legal name Instituto de Infertilidad y Genética México, S.C.) is a Mexico City-headquartered fertility institute founded in 2005 by Dr. Felipe Camargo, operating 20+ owned clinics across Mexico (Mexico City, Monterrey, Guadalajara, Querétaro, Mérida, Tijuana, Puebla) and the United States (San Diego, McAllen/Edinburg, Houston, Orange County) with 501–1,000 employees. The company provides assisted reproduction services — IVF, ICSI, PICSI, artificial insemination, egg/sperm donation and preservation, surrogacy, and maternal-fetal care — to heterosexual couples, LGBTQ+ couples, single individuals and international medical tourists from 40+ countries, reporting 75,000+ babies born cumulatively. Its differentiator is the proprietary TripleMed® platform, which integrates reproductive medicine with regenerative/genetic medicine (Ovagen® ovarian regeneration, Endogen® endometrial restoration, IVF MORE® mitochondrial restoration, Procelk® exosome therapy, PGT-A/PGT-M genetic testing, Eligender® sex selection, Clarix® NIPT) and metabolic medicine (Longevity Test, personalized ketogenic nutrition) under a single clinical roof. The business model combines fee-for-service treatment packages — closed-price multi-cycle programs with a partial money-back guarantee — with a B2B corporate wellness channel covering 500+ multinational employers and a 1,000+ referring-physician network. International patient services are coordinated through virtual consultations, travel logistics and multilingual follow-up. Ingenes is privately held with no disclosed external funding; Cofepris license, REDLARA Gold lab certification, ASRM and ESHRE affiliations provide regulatory anchoring, and US operations operate under HIPAA as a unified business unit.

Ingenes firmographics

Firmographics
Name
Ingenes
Legal name
Instituto de Infertilidad y Genética México, S.C.
Website
https://ingenes.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
251–500 employees
Short description
Ingenes is a Mexico-headquartered fertility institute operating 20+ clinics across Mexico and the United States, delivering IVF, regenerative and genetic reproductive medicine, and surrogacy programs to individuals, couples and medical tourists from 40+ countries.
Ownership category
akta.pro rank

Ingenes industry classification

Industry
Product category
Fertility and Reproductive Medicine Services
NAICS
Family Planning Centers (621410)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAC
Reproductive Endocrinology & Infertility (IVF/Fertility)
SECONDARYHLALAHAA
Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)

Keywords

  • Fertility treatments
  • Assisted reproduction
  • In vitro fertilization
  • Reproductive medicine
  • Surrogacy services

Where Ingenes is headquartered

Location

Headquarters

HQ city
Mexico City
HQ country
Mexico
HQ region
Latin America

Offices11 records

Markets served

Ingenes business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Medical Treatment Services: Ingenes generates revenue primarily through fee-for-service medical treatments including IVF, ICSI, insemination, surrogacy programs, egg/sperm preservation, donation programs, and maternal-fetal care. Treatments are sold as multi-cycle program packages with closed pricing (multiple cycles included in one price), with medication, studies, and procedures bundled.
  2. Multi-Cycle Programs with Money-Back Guarantee: Multi-cycle program bundles with partial refund if pregnancy is not achieved after contracted cycles. This de-risks the patient purchase decision and drives conversion for high-complexity treatments.
  3. Corporate Wellness Agreements: Over 500 multinational corporations purchase preferential access to Ingenes fertility benefits for their employees under corporate agreements, providing a B2B revenue stream.
  4. International / Medical Tourism: Patients from more than 40 countries travel to Ingenes locations in Mexico and the US, generating international patient revenue with coordinated travel, treatment, and follow-up services.

Pricing tiers

ModelBillingPrice
Outcome Based/ PerformanceMulti-year contractMulti-Cycle Programs with Guarantee

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Ingenes product offering

Product offering

Core offering

Ingenes operates a network of fertility clinics providing assisted reproduction treatments (IVF, ICSI, PICSI, artificial insemination), egg and sperm donation and preservation, surrogacy programs, and proprietary regenerative therapies (Ovagen®, Endogen®, IVF MORE®, Procelk®) under its integrated TripleMed® platform combining reproductive, regenerative/genetic, and metabolic medicine. It serves individual patients and couples (heterosexual, LGBTQ+, single) via 20+ branches in Mexico and the US, with closed-price multi-cycle packages and corporate wellness agreements.

Product overview

Ingenes is a reproductive health institute offering a comprehensive portfolio of assisted reproduction and fertility treatments, organized around its proprietary TripleMed® approach that integrates reproductive medicine, regenerative and genetic medicine, and metabolic medicine. The core offerings include FIV/ICSI/PICSI treatments, artificial insemination, egg and sperm donation services, fertility preservation, and the IVF MORE® mitochondrial restoration technique. Specialized services encompass genetic testing (PGT-A, PGT-M), sex selection (Eligender®), stem cell therapies (Ovagen®, Endogen®, Procelk®), and surrogacy programs. The institute operates 20+ branches across Mexico and the United States, serving patients from over 40 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • TripleMed®: Proprietary integrated medicine approach combining reproductive medicine, regenerative and genetic medicine, and metabolic medicine under one roof.
  • Ovagen®
  • Endogen®
  • Procelk®
  • IVF MORE®
  • Eligender®
  • Clarix®

Products and services

  • TripleMed® Integrated Fertility Program Comprehensive fertility treatment program integrating reproductive medicine (IVF, ICSI, insemination, surrogacy), regenerative and genetic medicine (stem cells, PGT-A/PGT-M, sex selection), and metabolic medicine (longevity testing, personalized nutritional intervention) for individuals and couples facing complex infertility.
  • In Vitro Fertilization (FIV) High-complexity assisted reproduction procedure for couples facing infertility challenges, including gamete retrieval, fertilization in laboratory, and embryo transfer.
  • FIV with ICSI IVF with intracytoplasmic sperm injection (ICSI), where a single sperm is directly injected into an egg for severe male factor infertility cases.
  • FIV with PICSI IVF with physiological ICSI (PICSI), selecting mature sperm based on hyaluronic acid binding to improve fertilization outcomes.
  • Artificial Insemination Low-complexity assisted reproduction treatment involving timed intrauterine insemination for patients with compatible infertility profiles.
  • Egg Donation (Ovodonación) Egg donation service using donor eggs for patients who cannot use their own eggs, accessed through the Mexican egg bank.
  • Sperm Donation Sperm donation service for patients requiring donor sperm, sourced from the Mexican and international sperm banks.
  • Egg Preservation Egg preservation (egg freezing) service for women delaying childbearing for social, oncological, or gender-transition-related reasons.
  • Sperm Preservation Sperm cryopreservation service for men, including those facing medical treatments affecting fertility.
  • Ovagen® Ovarian Regeneration Proprietary ovarian tissue regeneration therapy using stem cells, targeting women with low ovarian reserve including those aged 38–45 told their eggs are no longer viable.
  • Endogen® Endometrial Regeneration Proprietary endometrial regeneration therapy using stem cells to restore a damaged endometrium to receptivity for implantation in patients with failed IVF cycles.
  • IVF MORE® Egg Mitochondrial Restoration Proprietary mitochondrial restoration therapy that rejuvenates eggs at the mitochondrial level, offered to patients with multiple failed IVF attempts and no clear answers.
  • Procelk® Exosome-Based Stem Cell Therapy Proprietary exosome-based therapy applied to enhance gamete and embryo quality, used as part of the regenerative medicine branch within TripleMed.
  • PGT-A Preimplantation Genetic Testing Preimplantation genetic testing for aneuploidy (PGT-A) to screen embryos for chromosomal abnormalities before transfer.
  • PGT-M Preimplantation Genetic Testing Preimplantation genetic testing for monogenic disorders (PGT-M) to screen embryos for specific inherited genetic conditions before transfer.
  • Eligender® Sex Selection Sex selection service using genetic testing to choose the sex of the embryo for family balancing, offered as an additional service within the TripleMed framework.
  • Clarix® Non-Invasive Prenatal Test

Quantifiable outcome

  • 75,000+ babies born over 20 years of operation
  • +3 more outcomes

Companies that use Ingenes

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Ingenes technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Ingenes partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • 500+ Multinational Corporations (Corporate Wellness Partners)coreChannel Partner/ Reseller/ DistributorOver 500 multinational corporations have corporate agreements with Ingenes that include fertility medicine benefits for their teams. These agreements provide employees with preferential access, special conditions, and integral support for treatments including IVF, preservation, donation, and surrogacy.
  • 1,000+ Referring Physicians (gynecologists, endocrinologists, specialists)coreChannel Partner/ Reseller/ DistributorMore than 1,000 gynecologists, endocrinologists, and specialists refer patients to Ingenes from multiple countries. Ingenes works as a team with the treating physician, coordinates treatment, and returns the patient with complete follow-up to the referring doctor.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Ingenes competitors and assessment

Company assessment

Broad incumbents

  • Boston IVF: US-based fertility clinic network offering IVF, ICSI, PGT, and preservation across multiple sites. Comparable as a multi-clinic fertility operator with outcomes reporting, though more concentrated in the US than Ingenes' Mexico/US model.
  • Shady Grove Fertility: Major US fertility chain (part of Unified Women's Healthcare) with shared-risk and multi-cycle refund programs that closely mirror Ingenes' Programas Multiciclo structure, making it a direct comparator on outcomes-based pricing and employer benefit partnerships.
  • Reproductive Medicine Associates of New Jersey (RMANJ): Large US fertility practice group with high-volume outcomes reporting and PGT-focused programs. Comparable on outcome transparency, multi-clinic fertility operations, and integration of advanced genetic testing into the standard IVF pathway.
  • CCRM (Colorado Center for Reproductive Medicine): Large US fertility clinic network with proprietary lab protocols and aggressive expansion. Comparable on integrated reproductive + genetic medicine positioning and on multi-site specialty fertility model, though without Ingenes' regenerative medicine and medical tourism angles.

Direct peers

  • Instituto Valenciano de Infertilidad (IVI): Pioneering Spanish fertility institute that pioneered many techniques now standard across the industry; comparable to Ingenes on research-driven positioning, multi-country footprint, and international patient focus.
  • New Hope Fertility Center: US fertility clinic known for mild/mini-IVF protocols and high-volume international patient flow. Comparable to Ingenes on medical tourism orientation and on serving complex or repeat-failure patient cases.
  • IVI-RMA Global: World's largest fertility clinic network (now under KKR ownership) offering IVF, ICSI, PGT, egg donation, and preservation across Europe, Latin America, and beyond. Most directly comparable to Ingenes as a multi-country fertility chain with strong medical tourism and B2B employer channels.
  • Eugin: European fertility chain (formerly part of the NMC group) with cross-border patient flow from Latin America, including egg donation programs and multi-cycle packages. Comparable to Ingenes as a cross-border fertility operator with strong Latin American demand.

Regional players

  • Genea: Australian fertility clinic and technology provider operating a multi-site network across Australia and selected international markets. Comparable on clinic-network scale and proprietary lab/embryology investments, though regional.
  • ProcreaTec: Madrid-based fertility clinic catering significantly to international patients, particularly from Latin America and the Middle East. Comparable to Ingenes on cross-border medical tourism and premium positioning, though serving European rather than Mexican capacity.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Ingenes social profiles

Digital presence

Ingenes financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ingenes leadership team

Management profile

Number of profiles

Profiles1 record

Ingenes subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

Ingenes funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ingenes M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ingenes

What does Ingenes do?

Ingenes operates a network of fertility clinics providing assisted reproduction treatments (IVF, ICSI, PICSI, artificial insemination), egg and sperm donation and preservation, surrogacy programs, and proprietary regenerative therapies (Ovagen®, Endogen®, IVF MORE®, Procelk®) under its integrated TripleMed® platform combining reproductive, regenerative/genetic, and metabolic medicine. It serves individual patients and couples (heterosexual, LGBTQ+, single) via 20+ branches in Mexico and the US, with closed-price multi-cycle packages and corporate wellness agreements.

Is Ingenes a public or private company?

Ingenes is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Ingenes founded?

Ingenes was founded in 2005. It employs 251 to 500 people.

Where is Ingenes based?

Ingenes is headquartered in Mexico City, Mexico, in the Latin America region.

How does Ingenes make money?

Four revenue lines are on record. Medical Treatment Services are the primary driver. The others are multi-Cycle Programs with Money-Back Guarantee, corporate Wellness Agreements and international / Medical Tourism.

Who are Ingenes's main competitors?

Broad incumbents on record are Boston IVF, Shady Grove Fertility, Reproductive Medicine Associates of New Jersey (RMANJ) and CCRM (Colorado Center for Reproductive Medicine). Direct peers are Instituto Valenciano de Infertilidad (IVI), New Hope Fertility Center, IVI-RMA Global and Eugin. Regional players are Genea and ProcreaTec.

Does Ingenes have an API?

No public API is recorded for Ingenes.

What industry is Ingenes in?

Ingenes's product category is Fertility and Reproductive Medicine Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 621410 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales